Sources, Classification and Nomenclature of Drugs
On this page
01
Overview
02
What is a drug?
A drug (or medicine/pharmaceutical) is any chemical substance that, when introduced into a living system, produces a biological effect and is used for the diagnosis, prevention, treatment or relief of disease. The term comes from the Old French drogue — but the modern definition is precise: chemical substance + biological effect + medical purpose.
Key related terms that examiners like to pair with the definition:
- Pharmacology — the science of drugs: their sources, nature, properties, effects and uses.
- Pharmacotherapy — the use of drugs to treat disease (as opposed to surgery, radiotherapy or non-drug measures).
- Toxicology — the study of harmful effects of chemicals; every drug is a potential poison at a high enough dose (Paracelsus: "the dose makes the poison").
- Pharmacopoeia — an official book describing approved drugs, their preparation, quality and dosing standards.
03
Sources of drugs
Drugs originate from five broad sources. Knowing the source explains a drug's chemistry, cost and availability — and makes the examples easy to memorise because so many classic drugs are named after their origin.
Scroll the table sideways on a smaller screen.
| Source | How drugs arise | Classic examples |
|---|---|---|
| Plant (botanical) | Active constituents extracted from leaves, bark, roots, seeds or opium latex | Morphine (opium poppy), digoxin (foxglove), quinine/artemisinin (cinchona/Artemisia annua), atropine (deadly nightshade), aspirin precursor (willow bark) |
| Animal | Substances obtained from animal tissues or glands | Insulin (pork/beef pancreas — historical), heparin (pig intestine/lung), thyroxine, antisera and antivenoms, vaccines from chick embryos |
| Mineral (inorganic) | Inorganic salts and elements | Ferrous sulphate (iron), magnesium sulphate, sodium chloride infusions, calcium gluconate, potassium chloride, zinc sulphate |
| Synthetic / semi-synthetic | Made chemically in the laboratory; semi-synthetic = natural skeleton modified chemically | Aspirin (synthetic), sulphonamides, paracetamol; semi-synthetic: amoxicillin (from penicillin nucleus 6-APA), artemether |
| Biotechnological (recombinant) | Genetically engineered cells (bacteria/yeast/mammalian) produce the molecule | Recombinant human insulin, growth hormone, erythropoietin, monoclonal antibodies (e.g., rituximab), hepatitis B vaccine |
04
How drugs are classified
A single drug can be classified in several legitimate ways at once. When asked to "classify drugs", always state the basis of your classification first — marks are given for the framework, not just a list.
Scroll the table sideways on a smaller screen.
| Basis | What it groups by | Example groups | Strength / limitation |
|---|---|---|---|
| By source | Origin of the substance | Plant, animal, mineral, synthetic, biotech drugs | Simple and historical; says little about how drugs are used clinically |
| By chemical structure | Molecular skeleton | Penicillins, cephalosporins, steroids, alkaloids, sulphonamides | Predicts chemistry and cross-allergy (e.g., penicillin–cephalosporin); used by medicinal chemists |
| By pharmacological action | Effect on body function | Antihypertensives, analgesics, diuretics, anticoagulants | Most useful clinically; groups drugs that do the same job by any mechanism |
| By mechanism of action | Molecular target | ACE inhibitors, beta-blockers, proton-pump inhibitors, COX inhibitors | Deepest scientific basis; two drugs in one action group may act very differently |
| By therapeutic use | Condition treated | Antimalarials, antituberculous drugs, antidiabetics | Practical for treatment guidelines; one drug may appear in several groups |
| ATC system | Anatomical–Therapeutic–Chemical (WHO coding) | C09CA01 = losartan (C cardiovascular, 09 agents on RAAS, CA angiotensin II antagonists, 01 losartan) | The international standard for statistics and drug utilisation research |
The key insight: these systems overlap rather than compete. Atenolol is a synthetic drug (source), a beta-blocker (mechanism), an antihypertensive/antianginal (action and use) and C07AB03 in the ATC system — all four answers are correct for different questions.
05
Drug nomenclature: three names, one substance
Every marketed drug carries at least three names, and confusion between them is a recognised cause of medication error. Learn to distinguish them instantly:
- Chemical name — the full IUPAC description of the molecular structure. Unambiguous but impractically long: ibuprofen's chemical name is "(RS)-2-(4-(2-methylpropyl)phenyl)propanoic acid". Used in chemistry, never on prescriptions.
- International Nonproprietary Name (INN) — the official generic name selected by the WHO. One unique name per substance, placed in the public domain, usable freely by any manufacturer. This is the name used in pharmacopoeias, the Uganda Clinical Guidelines, teaching and — ideally — on every prescription.
- Brand (proprietary, trade) name — the manufacturer's registered trademark, e.g., Brufen®, Panadol®, Septrin®. One INN may have dozens of brand names; brands of the same drug may look completely different in packaging, strength and price.

National variants of the generic name also exist: the BAN (British Approved Name — e.g., adrenaline, frusemide) and the USAN (e.g., epinephrine, furosemide) sometimes differ from the INN, but WHO has progressively harmonised spellings (frusemide → furosemide). Uganda's Clinical Guidelines use INN spellings.
06
INN stems: reading a drug's class from its name
Since the 1970s the WHO has standardised stems: all members of a pharmacological class share a common word-ending (sometimes a prefix), so the class is visible in the name itself. A prescriber who knows the stems can guess a drug's action before opening a reference.
Scroll the table sideways on a smaller screen.
| Stem | Drug class | Examples |
|---|---|---|
| -olol | Beta-adrenergic blockers | Atenolol, propranolol, carvedilol |
| -pril | ACE inhibitors | Enalapril, lisinopril, captopril |
| -sartan | Angiotensin-II receptor blockers | Losartan, valsartan, telmisartan |
| -vastatin | HMG-CoA reductase inhibitors (statins) | Simvastatin, atorvastatin, rosuvastatin |
| -vir | Antivirals | Aciclovir, tenofovir (also -navir for protease inhibitors: ritonavir, lopinavir) |
| -caine | Local anaesthetics | Lidocaine, bupivacaine, procaine |
| -azepam / -azolam | Benzodiazepines | Diazepam, lorazepam, midazolam |
| -coxib | COX-2 selective inhibitors | Celecoxib, etoricoxib |
| -mab | Monoclonal antibodies | Infliximab, rituximab, trastuzumab |
| -tinib | Tyrosine-kinase inhibitors | Imatinib, erlotinib |
| cef- | Cephalosporins (prefix) | Cefalexin, ceftriaxone, cefixime |
| arte- | Artemisinin antimalarials (prefix) | Artemether, artesunate, dihydroartemisinin |
07
Why generic names matter in Uganda
Uganda's national drug policy mandates prescribing by generic (INN) name, and the Uganda Clinical Guidelines (UCG) print all medicines in generic form — brand names do not appear. The reasons are practical:
- Cost: generic medicines are typically far cheaper than branded equivalents — critical in a resource-limited system and for out-of-pocket patients.
- Continuity of supply: a prescription written as "amoxicillin 500 mg" can be filled from whatever batch or manufacturer is in stock at the National Medical Stores; a brand-written prescription cannot be substituted when that brand is out of stock.
- Safety: one name = one substance = fewer dispensing errors.
- Fair competition: generic prescribing opens tenders to multiple suppliers, improving availability.
A brand name is acceptable on a prescription only when it genuinely matters clinically (some narrow-therapeutic-index or modified-release products), and then the INN should still be added in brackets.
08
Clinical scenarios
Scenario 1 — Same drug, three names, one confused patient
A patient discharged on "Panadol® tablets for pain" visits a different pharmacy where only Emzor Paracetamol® is stocked, and buys ibuprofen "because the box looks the same". The prescriber's error was writing a brand name. Rewrite the prescription generically — Paracetamol tablets 1 g every 6–8 hours when required, maximum 4 g/day — and any pharmacy in the country can supply it. The teaching point: brand-name prescribing fragments care; INN prescribing makes the whole supply chain interchangeable for the patient's benefit.
Scenario 2 — Reading the stem at the ward shelf
During a night shift you find an unlabelled emergency tray containing atenolol, losartan, enalapril and amoxicillin. Using stems alone: -olol = beta-blocker (can drop blood pressure and heart rate), -sartan and -pril = both antihypertensives acting on the renin–angiotensin system, while amoxicillin (penicillin antibiotic) has no cardiovascular role. In 30 seconds you have sorted an antihypertensive bundle from an antibiotic without opening a reference book.
09
Key points
10
References
- Rang & Dale's Pharmacology (Library reference.)
- Goodman & Gilman's The Pharmacological Basis of Therapeutics (Library reference.)
- Katzung's Basic & Clinical Pharmacology (Library reference.)
- WHO International Nonproprietary Names (INN) Programme and Stem Book (Library reference.)
- Uganda Clinical Guidelines 2023, Ministry of Health (Library reference.)
11
Further reading
For deeper study, compare this lesson with current guidance and standard references from recognised medical and pharmaceutical organisations.
- WHO: International Nonproprietary Names programme
- WHO: ATC/DDD drug classification toolkit
- Uganda Ministry of Health Knowledge Management Portal (UCG & EMHSLU)
- DCM Year One Semester Two curriculum
For education only. Apply current Uganda Clinical Guidelines, the Essential Medicines and Health Supplies List of Uganda, and local protocols in clinical practice.